A drug to treat retinal diseases with drops instead of injections


(FECYT – Spanish Foundation for Science and Technology) The Spanish firm Sylentis has developed a compound to treat diseases of the retina, such as age-related macular degeneration and diabetic retinopathy, which will be administered by ophthalmic drops instead of intraocular injections. The drug, which has been tested in animals, is a small interfering RNA capable of penetrating the cells of the retina and blocking the formation of new blood vessels.

Leave A Reply

Your email address will not be published.